• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  09/28/2010
Trade Name:  Kapvay Extended Release Tablets
Generic or Proper Name (*):  clonidine
Indications Studied:  Treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications
Therapeutic Category:  Non-stimulant ADHD treatment
Ages Studied:  6-17 years
Study #:  3
Study Type:  Safety
Study Design:  Open Label
No Patients:  303
No Centers:  27
No Countries:  1
Countries:  US